The analysis used daily cholera case data separated by vaccination status to calibrate several stochastic models of disease transmission. At its baseline estimate, the model placed the basic reproduction number, R0, at 1.5, with a 95% credible interval of 1.2 to 1.9. This quantity describes how many secondary infections are generated by an infected person in a wholly susceptible population. A value above one indicates that an outbreak can expand without control measures, while the relatively modest estimate in Koungou is consistent with a setting in which transmission remained vulnerable to interruption through vaccination and other interventions.

The observational and modelling data covered 4,733 people deemed at risk in Koungou. Of these, 3,354 received CVD 103-HgR, representing 71% coverage. During the period from 19 April to 7 July 2024, 77 confirmed cholera cases were recorded with symptom onset in the analysed population. By comparing the epidemic trajectory among vaccinated and unvaccinated people, the investigators estimated that the vaccine prevented 87% of cholera cases at baseline. The 95% credible interval extended from 74% to 99%, indicating that even the lower bound represented substantial protection.

Those estimates remained comparatively stable when the researchers examined alternative assumptions in sensitivity analyses: vaccine effectiveness ranged from 75% to 91% across the scenarios considered. This robustness is important because real-world evaluations of outbreak vaccination are rarely as straightforward as controlled human challenge studies. Coverage may be uneven, doses may be administered at different times relative to exposure, people can move between areas, and other prevention measures may operate at the same time. The model attempted to account for these features by fitting multiple stochastic formulations to the observed case series rather than relying on a single simple comparison of attack rates.

The study responds to a changing global cholera landscape in which recurrent outbreaks and vaccine shortages have encouraged health authorities to use reactive campaigns, often administering a single dose of oral cholera vaccine. Most evidence for killed oral cholera vaccines has come from settings where two-dose regimens have been deployed over longer periods, leaving less information about the practical effectiveness of newer, live-attenuated alternatives when they are introduced rapidly. Vaxchora had previously shown high efficacy in human challenge studies, but its real-world performance during an active outbreak had not been established.

CVD 103-HgR is a live-attenuated vaccine, meaning it contains a weakened form of the cholera bacterium designed to stimulate immunity without causing the full clinical disease. Its one-dose schedule is operationally attractive when public-health teams need to reach a large population quickly or cannot arrange a second visit. The Mayotte analysis therefore tested a question of practical as well as biological importance: whether the vaccine’s performance would be retained when used rapidly in a community experiencing sustained transmission, rather than under the controlled exposure conditions of a challenge study.

Beyond individual protection, the researchers estimated the effect of the campaign by simulating what might have happened without vaccination. Under the baseline assumptions, the model projected that 536 cholera cases were averted, with a 95% credible interval of 240 to 824. The wider range of point estimates across sensitivity analyses extended from 152 to 1,228. This interval reflects the difficulty of inferring population-level impact from a single village outbreak, where relatively small changes in transmission, vaccine coverage, timing or case ascertainment can produce substantially different counterfactual totals.

The distinction between these two findings is central to the interpretation of the campaign. Vaccine effectiveness describes how well vaccination prevents cholera in vaccinated individuals under the conditions of the outbreak, whereas impact measures the total reduction in cases across the community, including indirect effects such as reduced transmission. High individual protection does not automatically translate into an equally precise estimate of cases prevented, especially when cases occur among people who were not vaccinated, transmission was already declining, or other control measures contributed to the observed pattern.

Taken together, the results support including live-attenuated oral cholera vaccines in reactive strategies when they are available and operationally appropriate. The findings do not mean that vaccination alone can control every outbreak: safe water, sanitation, hygiene, case detection, treatment and measures to interrupt transmission remain essential. They do, however, provide real-world evidence for a single-dose vaccine deployed during a fast-moving epidemic. The combination of high estimated effectiveness and a potentially substantial, though uncertain, reduction in cases supports Vaxchora as an additional tool in settings facing acute cholera resurgence and constrained vaccine supply, while also showing why the scale of population benefit must be assessed carefully rather than inferred from efficacy figures alone.

Subject of Research: Real-world effectiveness and population impact of single-dose Vaxchora oral cholera vaccination during the 2024 Mayotte outbreak.

Article Title: Short-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte

Article References: Brault, A., Herry, F., Mazzilli, S., Cristancho-Fajardo, L., Froidefond, M., Epinoux, M., Berot, M., Soler, M., Lapostolle, A., Camaglia, F., Charniga, K., Cholin, T., Jean, M., Fouere, T., Ahmed, A., Niang, M., Paireau, J., Lessler, J., Azman, A. S., … Cauchemez, S. (2026). Short-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte. Nature Communications. https://doi.org/10.1038/s41467-026-78733-0

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78733-0

Keywords: Vaxchora, cholera, Mayotte, oral cholera vaccine, CVD 103-HgR, vaccine effectiveness, outbreak modelling, disease transmission, public health, Short-term, effectiveness, impact

The research, led by Yeonji Jeon of the International Vaccine Institute in Seoul together with colleagues at Mozambique’s Instituto Nacional de Saúde and its Nampula delegation, set out to map how communities in a cholera-endemic region actually behave when illness strikes. Nampula Province experiences recurrent cholera outbreaks, making it a natural laboratory for understanding the interaction between community knowledge, physical access to healthcare, and the decision to seek treatment. Despite decades of global investment in cholera case management, the authors note that persistent gaps remain in understanding local health-seeking behaviors and what ordinary households actually know about the disease. Closing the case fatality gap, they argue, requires knowing not just where clinics are, but why people do or do not reach them.

To capture that picture, the team conducted a cross-sectional household survey between November 10 and 19, 2023, spanning urban Nampula city and the rural districts of Meconta and Monapo. In total, 831 households were enrolled, and trained teams collected information on healthcare access, health-seeking behavior, and cholera knowledge using tablet-based questionnaires. The statistical toolkit was deliberately conventional: Pearson Chi-square tests to detect differences between groups, followed by multivariate logistic regression to identify which factors were independently associated with whether households used healthcare facilities when cholera or diarrheal symptoms appeared. This design allowed the researchers to separate the effect of geography from the effects of education, awareness, and household circumstances, a distinction that proved decisive.

The first striking result concerns transportation and distance, the variables most often treated as the dominant obstacles to timely care. Across all three sites, walking was the primary mode of reaching a healthcare facility, cited by 55.9 percent of participants. Rural residents generally traveled farther and spent more time in transit than their urban counterparts, a predictable but important disparity in a province where health infrastructure is unevenly distributed. Yet distance and mode of travel did not translate into the behavioral pattern one might predict. When asked what they would do in the face of cholera or diarrheal symptoms, a remarkable 94 percent of participants said they would seek care at a healthcare facility, and households in rural Meconta showed exclusive reliance on formal facilities. The willingness to seek treatment, in other words, was already in place almost everywhere the survey reached.

That willingness made one finding all the more paradoxical. Households located within 500 meters of a healthcare facility were actually less likely to seek care, with an odds ratio of 0.2 and a p-value of 0.0417, meaning that proximity conferred no advantage and may even have discouraged facility use. The authors interpret this as evidence that behavioral determinants beyond physical proximity shape treatment decisions. Possible explanations range from overconfidence among those living closest to care, to assumptions that illness will resolve on its own, to social and economic factors that the survey’s distance measures cannot capture. Whatever the underlying mechanism, the result carries a hard lesson for program design: building clinics closer to communities is not, by itself, a guarantee that sick people will walk through their doors in time.

The second major pillar of the study measured what residents actually knew about cholera, and here the picture darkened considerably. Recognition of the disease’s most dramatic symptoms was high: 85 percent of participants identified watery diarrhea as a cholera symptom and 86 percent identified vomiting. But knowledge collapsed when it came to the symptom that actually kills. Only 17 percent identified dehydration as a feature of cholera, and awareness of oral rehydration solution, the simple sugar-and-salt mixture that remains the single most life-saving intervention in cholera care, stood at a critically low 2.2 percent. This knowledge profile has direct clinical consequences. A caregiver who recognizes vomiting but not the insidious signs of fluid loss may wait until a patient is already in deep shock before departing for a facility, undoing the advantage of the province’s otherwise high care-seeking rate.

Where does cholera knowledge come from in Nampula? Healthcare workers emerged as the dominant channel, cited by 61.5 percent of participants as their main source of information, a finding that underscores the enormous influence frontline clinicians exert beyond the consultation room. But the pattern diverged sharply by geography. Rural participants relied more heavily on community-based sources, while urban populations more often encountered cholera information through television and social media. This split matters for communication strategy: a radio or social media campaign tuned to urban consumption habits will simply not reach rural households, which depend on community structures, health workers, and local networks for health information. Any education effort that ignores these channel differences risks reinforcing precisely the knowledge gaps the survey documented.

The regression analysis distilled which factors most strongly predicted whether a household would actually visit a healthcare facility for cholera treatment. Two stood out. First, households in which the head had technical or vocational education were dramatically more likely to seek facility-based care, with an odds ratio of 19.9 and a p-value of 0.0178, an association so strong that education appears to function as an almost binary switch on health behavior. Second, and more immediately actionable, households in which a member exhibited dehydration symptoms were more likely to visit a healthcare facility, with an odds ratio of 4.5 and a p-value of 0.0258. In other words, when the visible danger of cholera becomes unmistakable, people do respond, which means the tragedy unfolds in the lag between the first symptoms and the first recognizable signs of dehydration, a lag that better community knowledge could shorten.

The authors draw a clear set of conclusions from these data. Low awareness of dehydration, oral rehydration solution, and the oral cholera vaccine persists across Nampula despite remarkably high healthcare utilization, which means the missing ingredient is not infrastructure but information. They call for strengthened community-based education, deeper engagement of health workers as information conduits, and expanded oral rehydration points, the low-threshold posts where rehydration therapy can begin before a patient deteriorates. These measures, the study argues, must proceed alongside clinical case management and vaccination, with particular intensity in rural settings where the knowledge deficits are widest and community channels, not mass media, carry the message.

For the wider global health community, the Nampula findings land at a moment when cholera is resurging across multiple continents and vaccine supplies remain chronically strained. The study’s core insight travels well beyond Mozambique: the geography of mortality in cholera is not the geography of clinics but the geography of knowledge. A mother who cannot recognize dehydration, a household unaware that a sachet of oral rehydration salts can arrest a fatal decline, and a community that has never heard of the cholera vaccine are all vulnerabilities that no facility can compensate for once the critical hours have passed. With 94 percent care-seeking already achieved and healthcare workers trusted as messengers, Nampula Province has laid the behavioral foundation on which targeted education could realistically be built. The remaining task, the study suggests, is to fill the seventeen percent and the two percent gaps, because those numbers measure exactly the distance between recognizing a symptom and recognizing a death in the making.

Subject of Research: Health-seeking behavior and cholera knowledge affecting timely treatment in Nampula Province, Mozambique

Article Title: Bridging the gaps: how knowledge and access to care influence timely cholera treatment and reduce deaths in Nampula Province, Mozambique

Article References: Jeon, Y., Baloi, L. D., Park, S., Manjor, S., Lee, H., Park, J. Y., Jang, G. H., You, Y. A., Kim, D. R., Koh, D.-H., Tilahun, S. T., Manjate, N., Tovele, A., Zacarias, M., Chabane, J., Barata, A., Lynch, J. A., Langa, J. P., & Park, S. E. (2026). Bridging the gaps: how knowledge and access to care influence timely cholera treatment and reduce deaths in Nampula Province, Mozambique. BMC Public Health. https://doi.org/10.1186/s12889-026-29539-8

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29539-8

Keywords: cholera, Mozambique, Nampula, health-seeking behavior, oral rehydration solution, dehydration, public health, case management, oral cholera vaccine, community health workers, household survey, diarrheal diseases

The research team, led by Chanda Mwamba and Tikulirekuti Banda of the Centre for Infectious Disease Research in Zambia, together with collaborators from the Zambia National Public Health Institute, the Ministry of Health, Unity Health Toronto and the World Health Organization’s Alliance for Health Policy and Systems Research, evaluated the implementation of Zambia’s Multisectoral Cholera Elimination Plan, or MCEP. The plan, running from 2019 to 2025, aims to reduce cholera-related mortality by ninety percent, in line with the global roadmap. To understand how the plan moved from paper to practice, the researchers applied six phases of the Knowledge-to-Action framework, a widely used implementation science model that tracks how evidence is adapted to local contexts, how barriers are assessed, how interventions are put in place, and how knowledge use is monitored, evaluated and sustained over time.

The study combined several qualitative methods to build a layered picture of implementation. The researchers independently reviewed the MCEP document itself, examining how global guidance had been contextualized for Zambian conditions. They then triangulated this documentary evidence with 24 key informant interviews involving policy-makers and implementers at national, provincial, district and facility levels, 12 in-depth interviews with cholera survivors, and four focus group discussions with 28 members of community-based neighbourhood health committees. Fieldwork took place between April 2020 and May 2021 in two contrasting cholera hotspots: Mpulungu District, a swampy lakeside setting, and Lusaka District, a densely populated periurban environment. Thematic analysis, guided by the Knowledge-to-Action domains, was used to organize and interpret the data, and findings were cross-checked across sources to strengthen credibility.

Zambia’s vulnerability to cholera is well documented. Between 1977 and 2018, the country endured 29 cholera emergencies, with recorded cases ranging from 14 to 13,500 and case fatality rates between 0.5 and 9.3 percent. These outbreaks occurred chiefly in periurban areas and fishing camps that share waters with the Democratic Republic of Congo, Mozambique, Tanzania and Zimbabwe, and are characterized by poor sanitation, inadequate water supply, deficient drainage and weak solid waste management. Rapid urbanization intensifies these pressures, while high cross-border movement with cholera-prone neighbours complicates control efforts. The 2017 to 2018 outbreak that preceded the study period affected seven of Zambia’s ten provinces, producing 5,905 suspected cases and 98 deaths, an experience that sharpened political attention on the elimination agenda.

The document review revealed that the MCEP strategically targets twelve identified cholera hotspots for oral cholera vaccine campaigns, aiming for quick, visible results and public confidence before embarking on larger infrastructure and behaviour-change projects. These hotspots were identified through epidemiological, geographical and contextual analyses, encompassing areas with recurrent outbreaks, poor water, sanitation and hygiene services, transit points, slums, flooding, fishing camps and refugee influxes. The plan rests on a decentralized multisectoral governance structure anchored in national frameworks such as Vision 2030 and the Seventh National Development Plan, and it operationalizes its strategy through technical working groups covering water, sanitation and hygiene, case management, surveillance and laboratory capacity, community engagement and vaccination. Local adaptations emerged as well: in Mpulungu, revitalized community-led total sanitation projects target open defecation around lakeshores, while in Lusaka, interventions included installing pipes and drainage systems, burying shallow boreholes, and creating designated rubbish collection points after outbreaks.

Despite this thoughtful design, the study uncovered formidable barriers that have produced fragmented implementation. Perhaps the most consequential is the absence of a dedicated budget line for the MCEP, which left financing dependent on ministries with different priorities and vulnerable to redirection, particularly during the COVID-19 pandemic. Participants described how funds arrived late and flowed toward temporary emergency measures, such as water tanks during outbreaks, rather than durable infrastructure. ‘Cholera is seen as health rather than a development issue,’ one non-governmental organization actor explained, noting that funding only materializes during outbreaks, which is expensive and diverts resources from developmental activities. Underfunding of water, sanitation and hygiene infrastructure shaped how communities received cholera guidance, since hygiene recommendations are difficult to follow where piped water, sewerage and drainage simply do not exist. Community health volunteers, meanwhile, reported demotivation stemming from a lack of allowances, protective equipment and transport.

Knowledge translation emerged as another critical weak point. National and provincial health leaders demonstrated solid understanding of the MCEP’s strategic direction, but facility-level implementers and non-governmental actors, particularly in Mpulungu, knew far less about the plan itself, with one participant admitting they were ‘learning of that document today’ despite being familiar with district and provincial cholera taskforces. Stakeholders even disagreed about whether implementation was fundamentally bottom-up or top-down, revealing inconsistent internal communication. Coordination also faltered because the response was perceived to be driven predominantly by the Ministry of Health, leaving other sectors with variable responsibility and resources. Participants consistently argued that stronger accountability, commitment and shared ownership across ministries were essential, and some pointed to the COVID-19 response, with its rapid policy-making and enforcement, as a model for how cholera guidelines might be more effectively communicated and upheld.

Nevertheless, the study documents meaningful progress. The appointment of a national cholera elimination coordinator and the formation of multisectoral technical working groups improved coordination and strengthened the case for investment in laboratory capacity, vaccines and infrastructure. Zambia became one of the first four countries to receive Global Task Force on Cholera Control funds in recognition of its elimination efforts, and the leadership team continues to lobby parliamentarians for inclusion of the MCEP in the national budget. Each level of the health system now maintains emergency preparedness plans, and a monitoring framework with strategic and programmatic indicators tracks case fatality, early detection, coordination, financing and vaccine coverage. Encouragingly, Zambia has recorded no cholera outbreak since 2019, which national informants attribute to high vaccine uptake in hotspot areas during and after the 2017-2018 outbreak, intensified environmental cleaning, and increased community knowledge about chlorine use and preventive measures.

The sustainability of these gains, however, is not assured. The researchers found gaps in evidence synthesis for knowledge users, limited monitoring and evaluation capacity, and no earmarked funds for locally determined operational research. The National Health Research Authority, which is responsible for knowledge synthesis, was integrated into technical working groups only after the MCEP was developed and is still building its systems. Drawing comparisons with Zimbabwe and Ethiopia, where multisectoral cholera elimination plans similarly face large funding gaps, the authors caution that global attention and resources diverted to COVID-19 may further threaten resource mobilization. The authors conclude that a multisectoral approach can generate the momentum and efficiencies needed to eliminate cholera in Zambia, but only if stakeholders are fully committed and funding is secured. They call for comprehensive advocacy, national and international budget commitments, robust monitoring and evaluation, and an adaptive collaborative strategy embedded within national guidelines that genuinely includes target communities in local translation and adaptation of the elimination agenda.

Subject of Research: Translating global cholera elimination guidelines into national multisectoral policy and local implementation in Zambia

Article Title: Raising the bar: translating global guidelines to achieve local policy on cholera elimination in Zambia—a qualitative case study

Article References: Mwamba, C., Banda, T., Mazaba, M., Mukonka, V., Malama, K., Hamweemba, E., Syulikwa, M., Chilengi, R., Sharma, A., Fahim, C., Marten, R., Yangchen, S., Straus, S., & The RAISE Project (2026). Raising the bar: translating global guidelines to achieve local policy on cholera elimination in Zambia—a qualitative case study. Health Research Policy and Systems, 24(S1), Article 71. https://doi.org/10.1186/s12961-026-01464-7

Image Credits: AI Generated

DOI: 10.1186/s12961-026-01464-7

Keywords: cholera elimination, Zambia, multisectoral approach, Knowledge-to-Action framework, Global Task Force on Cholera Control, oral cholera vaccine, water sanitation and hygiene, health policy implementation, knowledge translation, qualitative case study, sub-Saharan Africa, community engagement